Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Lyndsey Flanagan"'
Autor:
Lyndsey Flanagan, Aisling Coughlan, Nicola Cosgrove, Andrew Roe, Yu Wang, Stephanie Gilmore, Izabela Drozdz, Claire Comerford, Jeremy Ryan, Emma Minihane, Salma Parvin, Michael O’Dwyer, John Quinn, Philip Murphy, Simon Furney, Siobhan Glavey, Tríona Ní Chonghaile, Leukemia Research Foundation, Science Foundation Ireland, Breakthrough Cancer Research
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Multiple Myeloma (MM) is an incurable plasma cell malignancy, that despite an unprecedented increase in overall survival, lacks truly risk-adapted or targeted treatments. A proportion of patients with MM depend on BCL-2 for survival and recently the
Externí odkaz:
https://doaj.org/article/4727a29ad4d04f6192236d546d187e2e
Publikováno v:
Science Translational Medicine. 14
Venetoclax is a B cell lymphoma 2 (BCL-2)–selective antagonist used to treat chronic lymphocytic leukemia (CLL) and acute myelogenous leukemia (AML). Although this has been a promising therapeutic option for these patients, many of these patients d
Publikováno v:
Mesentery and Peritoneum. 7:AB054-AB054
Autor:
Clair Colee, Nicole Oberlag, Anjali Mawidmar, Edison Reid-McLaughlin, Lyndsey Flanagan, Synaida Maiche, Aaron Leconte
Publikováno v:
Journal of Biological Chemistry. 299:103186
Publikováno v:
Journal of Clinical Haematology. 2
Autor:
Triona Ni Chonghaile, John Quinn, Philip Murphy, Siobhan Glavey, Rachel Bleach, Claire Kelly, Lyndsey Flanagan
Publikováno v:
British Journal of Haematology. 190
Autor:
Michael O'Dwyer, Triona Ni Chonghaile, John Quinn, Philip Murphy, Siobhan Glavey, Lyndsey Flanagan
Publikováno v:
Blood. 138:4703-4703
Multiple Myeloma (MM) is a haematological malignancy characterised by clonal proliferation of plasma cells within the bone marrow (Landgren and Weiss, 2009). Unfortunately, despite the major improvements to the treatment of MM within the last decade,
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S90
Multiple Myeloma (MM) is a malignancy of the antibody-producing plasma cells. Despite improvements to treatment throughout the years, it remains an incurable and fatal disease [1]. Therefore, novel innovative therapies are needed for relapsed/refract
Publikováno v:
The FASEB Journal. 34:1-1
Autor:
Flanagan L; Physiology and Medical Physics, Royal College of Surgeons in Ireland, 123 St. Stephen's Green, Dublin 2., Coughlan A; Physiology and Medical Physics, Royal College of Surgeons in Ireland, 123 St. Stephen's Green, Dublin 2., Cosgrove N; Physiology and Medical Physics, Royal College of Surgeons in Ireland, 123 St. Stephen's Green, Dublin 2., Roe A; Physiology and Medical Physics, Royal College of Surgeons in Ireland, 123 St. Stephen's Green, Dublin 2., Wang Y; Physiology and Medical Physics, Royal College of Surgeons in Ireland, 123 St. Stephen's Green, Dublin 2., Gilmore S; Physiology and Medical Physics, Royal College of Surgeons in Ireland, 123 St. Stephen's Green, Dublin 2., Drozdz I; Department of Pathology, Royal College of Surgeons in Ireland., Comerford C; Department of Pathology, Royal College of Surgeons in Ireland; Department of Haematology, Beaumont Hospital, Dublin., Ryan J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Minihane E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Parvin S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., O'Dwyer M; Department of Medicine/Haematology, University of Galway, Galway., Quinn J; Department of Pathology, Royal College of Surgeons in Ireland; Department of Haematology, Beaumont Hospital, Dublin., Murphy P; Department of Pathology, Royal College of Surgeons in Ireland; Department of Haematology, Beaumont Hospital, Dublin., Furney S; Physiology and Medical Physics, Royal College of Surgeons in Ireland, 123 St. Stephen's Green, Dublin 2., Glavey S; Department of Pathology, Royal College of Surgeons in Ireland; Department of Haematology, Beaumont Hospital, Dublin., Chonghaile TN; Physiology and Medical Physics, Royal College of Surgeons in Ireland, 123 St. Stephen's Green, Dublin 2. tnichonghaile@rcsi.com., Foundation LR; Triona Ni Chonghaile, Lyndsey Flanagan., Ireland SF; Triona Ni Chonghaile., Research BC; Lyndsey Flanagan.
Publikováno v:
Haematologica [Haematologica] 2024 Sep 01; Vol. 109 (9), pp. 2930-2943. Date of Electronic Publication: 2024 Sep 01.